Talphera (TLPH) Non-Current Deffered Revenue (2010 - 2022)
Talphera (TLPH) posted quarterly Non-Current Deffered Revenue of $1.0 million for Q4 2022, down 9.99% year-over-year from $1.2 million in Q4 2021, and down 2.63% quarter-over-quarter from $1.1 million in Q3 2022.
Talphera (TLPH) Non-Current Deffered Revenue (2010 - 2022) Analysis & Trends
Talphera's Non-Current Deffered Revenue history runs 13 years deep, the most recent figure standing at $1.0 million for Q4 2022.
- In Q4 2022, Non-Current Deffered Revenue fell 9.99% year-over-year to $1.0 million; the TTM figure through Dec 2022 stood at $1.0 million (down 9.99% YoY), while the FY2022 annual figure was $1.0 million, down 9.99% from the prior year.
- Non-Current Deffered Revenue for Q4 2022 stood at $1.0 million, down from $1.1 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $3.4 million in Q1 2018, with the low at $1.0 million in Q4 2022.
- The 5-year median for Non-Current Deffered Revenue is $2.8 million (2019), against an average of $2.3 million.
- The sharpest annual moves came in 2018 and 2022: Non-Current Deffered Revenue jumped 1108.61% in 2018, then decreased 13.99% in 2022.
- Talphera's Non-Current Deffered Revenue stood at $3.1 million in 2018, then declined by 10.01% to $2.8 million in 2019, then declined by 2.79% to $2.8 million in 2020, then plunged by 58.21% to $1.2 million in 2021, then declined by 9.99% to $1.0 million in 2022.
- Business Quant data shows TLPH's Non-Current Deffered Revenue at $1.0 million in Q4 2022, $1.1 million in Q3 2022, and $1.1 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 1.24 Mn |
| Mar 31, 2020 | 2.75 Mn |
| Dec 31, 2019 | 2.83 Mn |
| Sep 30, 2019 | 2.91 Mn |
| Jun 30, 2019 | 2.99 Mn |
| Mar 31, 2019 | 3.07 Mn |
| Dec 31, 2018 | 3.15 Mn |
| Sep 30, 2018 | 3.23 Mn |
| Jun 30, 2018 | 3.31 Mn |
| Mar 31, 2018 | 3.38 Mn |
| Dec 31, 2017 | 3.46 Mn |
| Sep 30, 2017 | 267,000.00 |
| Jun 30, 2017 | 3.64 Mn |
| Mar 31, 2017 | 3.73 Mn |
| Dec 31, 2016 | 43,000.00 |